Document Detail

Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS.
MedLine Citation:
PMID:  11274309     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Spinal muscular atrophy (SMA) results from mutations of the survival motor neuron (SMN) gene on chromosome 5. The SMN gene exists in two highly homologous copies, telomeric (SMN1) and centromeric (SMN2). SMA is caused by mutations in SMN1 but not SMN2. The clinical phenotype of SMA appears to be related to the expression of SMN2. Patients suffering from the milder forms of SMA carry more copies of the SMN2 gene compared with patients with more severe SMA. It is suggested that the SMN2 gene is translated into an at least partially functional protein that protects against loss of motor neurons. OBJECTIVE: To investigate whether genetic mechanisms implicated in motor neuron death in SMA have a role in ALS. METHODS: The presence of deletions of exons 7 and 8 of SMN1 and SMN2 was determined in 110 patients with sporadic ALS and compared with 100 unaffected controls. RESULTS: The presence of a homozygous SMN2 deletion was overrepresented in patients with ALS compared with controls (16% versus 4%; OR, 4.4; 95% CI, 1.4 to 13.5). Patients with a homozygous SMN2 deletion had a shorter median time of survival (p < 0.009). Furthermore, multivariate regression analysis showed that the presence of an SMN2 deletion was independently associated with survival time (p < 0.02). No homozygous deletions in SMN1 were found. Carrier status of SMA appeared to be equally present in patients and controls (1 in 20). CONCLUSION: These results indicate that, similar to SMA, the SMN2 gene can act as a prognostic factor and may therefore be a phenotypic modifier in sporadic ALS. Increasing the expression of the SMN2 gene may provide a strategy for treatment of motor neuron disease.
J H Veldink; L H van den Berg; J M Cobben; R P Stulp; J M De Jong; O J Vogels; F Baas; J H Wokke; H Scheffer
Related Documents :
1639379 - Physical and genetic characterization of the distal segment of the myotonic dystrophy a...
8481629 - Heterozygotic gene expression in endomyocardial biopsies: a new diagnostic tool confirm...
8315649 - Entry of nephrons into the collecting duct network of the avian kidney: a comparison of...
8415729 - Chromosomal rearrangement segregating with adrenoleukodystrophy: associated changes in ...
12207929 - Congenital muscular dystrophy with adducted thumbs, ptosis, external ophthalmoplegia, m...
11274309 - Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in spora...
20559519 - Genetic instability in gastric epithelial neoplasias categorized by the revised vienna ...
21311099 - A two-locus system controls susceptibility to colitis-associated colon cancer in mice.
17264249 - Aurora b expression correlates with aggressive behaviour in glioblastoma multiforme.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Neurology     Volume:  56     ISSN:  0028-3878     ISO Abbreviation:  Neurology     Publication Date:  2001 Mar 
Date Detail:
Created Date:  2001-03-29     Completed Date:  2001-05-17     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0401060     Medline TA:  Neurology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  749-52     Citation Subset:  AIM; IM    
Department of Neurology, University Medical Center Utrecht, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age of Onset
Amyotrophic Lateral Sclerosis / genetics*,  physiopathology*
Cyclic AMP Response Element-Binding Protein
Gene Deletion*
Middle Aged
Nerve Tissue Proteins / genetics*
RNA-Binding Proteins
SMN Complex Proteins
Survival of Motor Neuron 1 Protein
Survival of Motor Neuron 2 Protein
Time Factors
Reg. No./Substance:
0/Cyclic AMP Response Element-Binding Protein; 0/Nerve Tissue Proteins; 0/RNA-Binding Proteins; 0/SMN Complex Proteins; 0/SMN1 protein, human; 0/SMN2 protein, human; 0/Survival of Motor Neuron 1 Protein; 0/Survival of Motor Neuron 2 Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Rapid initiation of gabapentin: a randomized, controlled trial.
Next Document:  Hospitalization in amyotrophic lateral sclerosis: causes, costs, and outcomes.